Profile data is unavailable for this security.
About the company
Embecta Corp. is a global medical device company. The Company is focused on providing solutions to people living with diabetes. The Company has a portfolio of products, including a range of pen needles, syringes and safety injection devices, which are complemented by its digital application designed to assist people with managing their diabetes. Its pen needles are sterile, single-use, medical devices, designed to be used in conjunction with pen injectors that inject insulin or other diabetes medications. The Company also sells safety pen needles, which have shields on both ends of the cannula that automatically deploy after the injection to help prevent needlestick exposure and injury during injection and disposal. In addition to pen needles, it sells sterile, single-use insulin syringes, which are used to inject insulin drawn from insulin vials. It distributes its products through a variety of channels, including retail, hospitals, pharmacies and other institutional channels.
- Revenue in USD (TTM)1.12bn
- Net income in USD55.30m
- Incorporated2021
- Employees2.20k
- LocationEmbecta Corp300 Kimball Drive, Suite 300PARSIPPANY NJ 07054United StatesUSA
- Phone+1 (862) 401-0000
- Fax+1 (302) 655-5049
- Websitehttps://www.embecta.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MaxCyte Inc | 41.29m | -37.92m | 393.57m | 143.00 | -- | 1.69 | -- | 9.53 | -0.3675 | -0.3675 | 0.3998 | 2.23 | 0.1488 | 0.4558 | 4.27 | 288,727.30 | -13.67 | -13.18 | -14.54 | -14.33 | 88.51 | 88.79 | -91.85 | -62.96 | 9.97 | -- | 0.00 | -- | -6.72 | 19.89 | -60.89 | -- | 39.13 | -- |
| Nevro Corp | 425.17m | -92.21m | 414.13m | 1.22k | -- | 1.40 | -- | 0.974 | -2.57 | -2.57 | 11.82 | 8.06 | 0.6868 | 1.24 | 5.37 | 349,937.40 | -14.90 | -13.64 | -17.15 | -16.68 | 68.22 | 68.54 | -21.69 | -20.67 | 4.94 | -- | 0.4191 | -- | 4.63 | 1.88 | -3,172.74 | -- | 0.9012 | -- |
| ZimVie Inc | 457.43m | -56.05m | 430.09m | 2.60k | -- | 1.04 | -- | 0.9402 | -2.12 | -14.87 | 17.33 | 15.12 | 0.3213 | 1.07 | 3.91 | 175,935.80 | -3.94 | -- | -4.56 | -- | 63.48 | 65.51 | -12.25 | -8.73 | 2.32 | -0.5562 | 0.5541 | -- | -1.26 | -16.08 | -19.50 | -- | -23.70 | -- |
| Pulse Biosciences Inc | 0.00 | -42.21m | 431.86m | 56.00 | -- | 9.72 | -- | -- | -0.8936 | -0.8936 | 0.00 | 0.8044 | 0.00 | -- | -- | 0.00 | -61.61 | -93.21 | -67.89 | -104.99 | -- | -- | -- | -12,332.25 | -- | -- | 0.00 | -- | -100.00 | -- | 27.85 | -- | -15.20 | -- |
| Surmodics Inc | 142.96m | 13.50m | 462.53m | 376.00 | 33.86 | 3.74 | 20.80 | 3.24 | 0.9597 | 0.9597 | 10.14 | 8.69 | 0.8194 | 2.05 | 6.66 | 380,220.80 | 7.74 | -1.85 | 8.69 | -2.18 | 79.11 | 82.93 | 9.44 | -2.98 | 3.59 | 9.66 | 0.1921 | -- | 32.65 | 10.27 | 94.37 | -- | -27.02 | -- |
| Pacific Biosciences of California Inc | 200.52m | -306.74m | 490.35m | 796.00 | -- | 0.6987 | -- | 2.45 | -1.21 | -1.21 | 0.7907 | 2.62 | 0.1142 | 2.70 | 7.24 | 251,910.80 | -17.46 | -16.19 | -19.45 | -17.81 | 28.03 | 37.35 | -152.97 | -136.21 | 7.21 | -22.45 | 0.5601 | -- | 56.29 | 20.59 | 2.39 | -- | 36.68 | -- |
| Orthofix Medical Inc | 746.64m | -151.40m | 508.73m | 1.63k | -- | 0.8442 | -- | 0.6814 | -4.15 | -4.15 | 20.33 | 16.11 | 1.08 | 1.62 | 7.08 | 456,940.60 | -21.88 | -8.88 | -26.68 | -10.96 | 65.13 | 72.37 | -20.28 | -9.28 | 1.20 | -16.11 | 0.1595 | -- | 62.06 | 10.51 | -666.60 | -- | 30.01 | -- |
| Nano-X Imaging Ltd | 9.91m | -60.78m | 539.95m | 164.00 | -- | 2.76 | -- | 54.51 | -1.08 | -1.08 | 0.1757 | 3.38 | 0.0419 | -- | 8.05 | 60,396.34 | -25.72 | -30.98 | -28.14 | -35.10 | -66.55 | -- | -613.59 | -1,527.24 | 5.56 | -- | 0.0175 | -- | 15.47 | -- | 46.33 | -- | 114.35 | -- |
| Iradimed Corp | 67.69m | 17.92m | 566.03m | 148.00 | 31.77 | -- | 39.39 | 8.36 | 1.41 | 1.41 | 5.31 | -- | -- | -- | -- | 457,333.40 | -- | 13.16 | -- | 14.58 | 76.57 | 76.55 | 26.48 | 21.46 | -- | -- | -- | 68.13 | 23.00 | 16.59 | 34.02 | 22.22 | 97.77 | -- |
| Jin Medical International Ltd | 19.98m | 3.25m | 566.70m | 269.00 | 162.19 | 23.83 | 158.37 | 28.37 | 0.0223 | 0.0223 | 0.1353 | 0.1519 | 0.7557 | 1.85 | 5.00 | 74,260.52 | 12.28 | -- | 16.62 | -- | 33.02 | -- | 16.25 | -- | 3.02 | -- | 0.0582 | -- | -7.58 | -- | 2.84 | -- | -- | -- |
| SI-Bone Inc | 138.89m | -43.34m | 583.12m | 344.00 | -- | 3.41 | -- | 4.20 | -1.13 | -1.13 | 3.62 | 4.16 | 0.716 | 1.57 | 6.52 | 403,738.40 | -22.34 | -27.88 | -25.24 | -30.94 | 78.78 | 85.03 | -31.20 | -51.09 | 8.15 | -- | 0.1756 | -- | 30.52 | 20.19 | 29.25 | -- | 52.62 | -- |
| Embecta Corp | 1.12bn | 55.30m | 584.43m | 2.20k | 10.58 | -- | 6.50 | 0.5207 | 0.9598 | 0.9598 | 19.47 | -13.78 | 0.9296 | 2.57 | 19.35 | 510,181.80 | 4.58 | -- | 6.44 | -- | 66.55 | -- | 4.93 | -- | 1.75 | 1.67 | 1.94 | -- | -0.7703 | -- | -68.52 | -- | -- | -- |
| Varex Imaging Corp | 877.80m | 44.60m | 632.95m | 2.30k | 23.23 | 1.11 | 8.01 | 0.7211 | 0.6712 | 0.6712 | 16.65 | 14.01 | 0.7245 | 1.95 | 5.90 | 365,750.00 | 3.72 | 0.9913 | 4.32 | 1.18 | 32.37 | 31.70 | 5.14 | 1.36 | 2.37 | 2.85 | 0.4322 | -- | 3.96 | 2.93 | 59.08 | 18.88 | 0.2924 | -- |
| Fulgent Genetics Inc | 289.21m | -167.83m | 642.86m | 1.18k | -- | 0.5612 | -- | 2.22 | -5.64 | -5.64 | 9.71 | 38.31 | 0.2207 | -- | 5.57 | 244,267.70 | -13.37 | 16.70 | -14.25 | 18.37 | 36.12 | 67.89 | -60.59 | 29.06 | -- | -- | 0.0048 | 0.00 | -53.27 | 68.41 | -217.03 | -- | 57.08 | -- |
| Treace Medical Concepts Inc | 187.12m | -49.53m | 681.30m | 516.00 | -- | 4.92 | -- | 3.64 | -0.8154 | -0.8154 | 3.08 | 2.23 | 0.9107 | 1.45 | 5.56 | 362,631.80 | -24.10 | -- | -29.51 | -- | 81.20 | -- | -26.47 | -- | 3.76 | -- | 0.2776 | -- | 31.92 | -- | -15.68 | -- | -- | -- |
| Atrion Corp | 169.33m | 19.41m | 730.29m | 712.00 | 37.65 | 3.01 | 21.16 | 4.31 | 11.02 | 11.02 | 96.13 | 138.01 | 0.6444 | 1.44 | 7.21 | 237,817.40 | 7.39 | 11.96 | 7.85 | 12.62 | 36.84 | 41.99 | 11.46 | 19.05 | 2.57 | 92.92 | 0.00 | 42.42 | -7.73 | 2.12 | -44.55 | -10.74 | 4.98 | 11.27 |
Data as of May 03 2024. Currency figures normalised to Embecta Corp's reporting currency: US Dollar USD
62.49%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 31 Dec 2023 | 8.67m | 15.06% |
| The Vanguard Group, Inc.as of 31 Dec 2023 | 6.90m | 11.99% |
| Millennium Management LLCas of 31 Dec 2023 | 3.64m | 6.32% |
| River Road Asset Management LLCas of 31 Mar 2024 | 3.45m | 5.99% |
| Yacktman Asset Management LPas of 31 Mar 2024 | 2.82m | 4.89% |
| American Century Investment Management, Inc.as of 31 Dec 2023 | 2.61m | 4.53% |
| SSgA Funds Management, Inc.as of 31 Dec 2023 | 2.52m | 4.37% |
| Fidelity Management & Research Co. LLCas of 31 Dec 2023 | 2.37m | 4.12% |
| Janus Henderson Investors US LLCas of 31 Dec 2023 | 1.72m | 2.99% |
| Charles Schwab Investment Management, Inc.as of 31 Dec 2023 | 1.29m | 2.24% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
